Abstract
The cardiac action potential can be divided into five distinct phases designated phases 0–4. The exact shape of the action potential comes about primarily as an orchestrated function of ion channels. The present review will give an overview of ion channels involved in generating the cardiac action potential with special emphasis on potassium channels involved in phase 3 repolarization. In humans, these channels are primarily Kv11.1 (hERG1), Kv7.1 (KCNQ1) and Kir2.1 (KCNJ2) being the responsible α‐subunits for conductingIKr,IKsandIK1. An account will be given about molecular components, biophysical properties, regulation, interaction with other proteins and involvement in diseases. Both loss and gain of function of these currents are associated with different arrhythmogenic diseases. The second part of this review will therefore elucidate arrhythmias and subsequently focus on newly developed chemical entities having the ability to increase the activity ofIKr,IKsandIK1. An evaluation will be given addressing the possibility that this novel class of compounds have the ability to constitute a new anti‐arrhythmic principle. Experimental evidence fromin vitro,ex vivoandin vivosettings will be included. Furthermore, conceptual differences between the short QT syndrome andIKractivation will be accounted for.

This publication has 395 references indexed in Scilit: